T
Tao Zhou
Researcher at Zhejiang Gongshang University
Publications - 100
Citations - 2518
Tao Zhou is an academic researcher from Zhejiang Gongshang University. The author has contributed to research in topics: Kojic acid & Medicine. The author has an hindex of 24, co-authored 86 publications receiving 1818 citations. Previous affiliations of Tao Zhou include King's College London.
Papers
More filters
Journal ArticleDOI
Design of iron chelators with therapeutic application
TL;DR: The factors which should be considered when designing clinically useful iron chelators are discussed and the potential applications in the treatment of neurodegenerative disorders and microbial infection are highlighted.
Journal ArticleDOI
Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands
David J. Berry,Yongmin Ma,Yongmin Ma,James R. Ballinger,Richard Tavaré,Alexander Koers,Kavitha Sunassee,Tao Zhou,Saima Nawaz,Gregory E. D. Mullen,Robert C. Hider,Philip J. Blower +11 more
TL;DR: A new tripodal tris(hydroxypyridinone) bifunctional chelator for gallium allows easy production of (68)Ga-labelled proteins rapidly under mild conditions in high yields at exceptionally high specific activity and low concentration.
Journal ArticleDOI
Carboxymethylated degraded polysaccharides from Enteromorpha prolifera: Preparation and in vitro antioxidant activity.
TL;DR: The antioxidant activity of CDPE was found to be greatly improved in comparison with degraded polysaccharide (DPE) and crude poly Saccharide from Enteromorpha prolifera (PE).
Journal ArticleDOI
Iron binding dendrimers: a novel approach for the treatment of haemochromatosis.
Tao Zhou,Hendrik Neubert,Ding Yong Liu,Zu Dong Liu,Yong Min Ma,Xiao Le Kong,Wei Luo,Sykes Mark,Robert C. Hider +8 more
TL;DR: A hydroxypyridinone-based dendrimer was demonstrated to be highly efficient at reducing the absorption of iron(III) in rat intestine and may find an application in the treatment of iron overload.
Journal ArticleDOI
Chelating agents for the treatment of systemic iron overload.
TL;DR: A newly emerging range of iron chelators will enable clinicians to apply iron chelation methodology to other disease states and to begin to design personalised chelation regimes.